Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Search for new drug using genomic technology brings together 3 companies in collaboration

July 19, 1996

Myriad Genetics and Intermountain Health Care collaborate on CNS disorders

July 19, 1996

Stat4 gene research at Tularik and Harvard University

July 19, 1996

Neuropeptide Y Y5 receptor linked to obesity and eating disorders

July 19, 1996

Roche begins screening for obesity drug candidates

July 19, 1996

C-Maf T-cell switch factor: Important component of Boston Life Science's R&D

July 19, 1996

Genome Therapeutics and Merck & Co. sign licensing agreement

July 19, 1996

Roche licenses PCR technology to Immuno

July 12, 1996

GenPharm describes high-affinity human IgG monoclonal antibodies

July 12, 1996

LCR Technology covered under U.S. patent

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...